Skip to content

Robert Rapaport, M.D.

NPI 1073580858ActiveIndividual· Pediatrics, Pediatric Endocrinology· New York, NY

Pediatrics, Pediatric Endocrinology (M.D.) in New York, New York, licensed in NY, with an NPI issued in March 2006. Enrolled in Medicare as practitioner - pediatric medicine. Novo Nordisk Inc was the largest of 6 companies reporting payments in 2025, $15,757 in all, mostly consulting fees.

Overview

NPI1073580858
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedMar 1, 2006
Last updated in NPPESMar 26, 2013

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (NY)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$15,757 · 18 payments from 6 companies
  • 2024$27,689 · 12 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$10,004 · 5 payments
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3,825 · 2 payments
  • Travel and Lodging$971.35 · 2 payments
  • Food and Beverage$956.53 · 9 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in New York

All 52 Pediatrics, Pediatric Endocrinology providers in New York · All Pediatrics, Pediatric Endocrinology providers in New York